Evidence mapPaperPMID 42193262Full record

ArticleAntioxidants (Basel, Switzerland)2026

Selective MIF Enolase Inhibitor TE-91 Regulates M1 Polarization and Associated Metabolic Reprogramming.

Péter Deák, Nikoletta Kálmán, Csenge Antus, Eva M Böhm, Marcell Krekó, Eszter Vámos, Viola Bagóné Vántus, Katalin Böddi, Lilla Makszin, Tamás Lóránd and 2 more

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Péter DeákDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0009-0005-7725-9103
Nikoletta KálmánDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0001-6827-9894
Csenge AntusDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0009-0008-7880-8153
Eva M BöhmOtto-Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, A-8010 Graz, Austria.ORCID 0000-0003-4898-884X
Marcell KrekóDepartment of Pharmaceutical Chemistry, Semmelweis University, H-1092 Budapest, Hungary.
Eszter VámosDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0003-0622-442X
Viola Bagóné VántusDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0001-7557-3004
Katalin BöddiDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0009-0009-2143-2009
Lilla MakszinInstitute of Bioanalysis, University of Pécs, Medical School, Szentágothai Research Center, H-7624 Pécs, Hungary.ORCID 0000-0002-9764-4763
Tamás LórándDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0002-0599-0758
Ferenc GallyasDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0002-1906-4333
Balázs RadnaiDepartment of Biochemistry and Medical Chemistry, University of Pécs, Medical School, H-7624 Pécs, Hungary.ORCID 0000-0002-7147-0080

Funding

János Bolyai Research Scholarship (Hungarian Academy of Sciences).Thematic Excellence Programme of the National Research, Development and Innovation Fund, Ministry of Culture and Innovation of Hungary. TKP2021-EGA-17
6 · The paper itself

Abstract

Macrophage migration inhibitory factor (MIF) has been shown to induce M1 macrophage polarization with oxidative stress and associated metabolic reprogramming. Several tautomerase inhibitors were shown to selectively inhibit either MIF's ketonase or enolase sub-activities. In this study, we aimed to investigate the role of enolase sub-activity in M1 polarization using the selective enolase inhibitor TE-91. We performed in silico molecular docking analysis and physicochemical characterization of TE-91. LPS + IFN-γ-induced RAW264.7 cells were applied as a model for M1 macrophage activation. We performed ROS and nitrite determinations, ELISA, qPCR, and immunoblot analysis, and measured mitochondrial oxygen consumption rate and extracellular acidification rate. Here, we reveal that TE-91 might directly bind to the MIF tautomerase active site. Furthermore, TE-91 reduces M1 activation by enhancing oxidative phosphorylation and reducing the glycolytic activity in LPS + IFN-γ-induced macrophage cells. In the same model, TE-91 reduces TNF-α, IL-6, CCL2, and iNOS mRNA transcription yet fails to modulate PARP1 and SOD2 mRNA transcription. It also decreases ROS, nitrite, and IL-6 production without influencing TNF-α and CCL2 protein production. TE-91 was unable to reduce either HIF-1α mRNA transcription or its protein expression. Finally, TE-91 reduced IL-1β cleavage, without affecting IL-1β protein expression. These results may highlight the importance of tautomerase sub-activities in M1 polarization.

Indexed as

glycolysisM1 polarizationmetabolic reprogrammingMIFoxidative burstOXPHOStautomerase

Identifiers

PMID42193262
PMCPMC13203694

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.